{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T11:57:37Z","timestamp":1772798257907,"version":"3.50.1"},"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2017,1,19]],"date-time":"2017-01-19T00:00:00Z","timestamp":1484784000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Fondo de Investigaciones Sanitarias","award":["PI 14\/1567, PI13\/00047, PIE13\/00051"],"award-info":[{"award-number":["PI 14\/1567, PI13\/00047, PIE13\/00051"]}]},{"name":"ISCIII-RETIC REDinREN","award":["RD12\/0021"],"award-info":[{"award-number":["RD12\/0021"]}]},{"DOI":"10.13039\/100012818","name":"Comunidad de Madrid","doi-asserted-by":"crossref","award":["sGEN\/0247\/2006, S2010\/BMD-2378"],"award-info":[{"award-number":["sGEN\/0247\/2006, S2010\/BMD-2378"]}],"id":[{"id":"10.13039\/100012818","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009664","name":"Spanish Society of Cardiology","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009664","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Spanish Heart Foundation"},{"name":"RECAVA","award":["RD06\/0014\/0035"],"award-info":[{"award-number":["RD06\/0014\/0035"]}]},{"name":"Instituto de Salud Carlos III FEDER","award":["RD09\/0076\/00101"],"award-info":[{"award-number":["RD09\/0076\/00101"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0169826","type":"journal-article","created":{"date-parts":[[2017,1,19]],"date-time":"2017-01-19T18:54:52Z","timestamp":1484852092000},"page":"e0169826","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":21,"title":["Use of Proton-Pump Inhibitors Predicts Heart Failure and Death in Patients with Coronary Artery Disease"],"prefix":"10.1371","volume":"12","author":[{"given":"Ana Mar\u00eda","family":"Pello L\u00e1zaro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Crist\u00f3bal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Antonio","family":"Franco-Pel\u00e1ez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nieves","family":"Tar\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1lvaro","family":"Ace\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roc\u00edo","family":"Carda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Huelmos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Luisa","family":"Mart\u00edn-Mariscal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas","family":"Fuentes-Antras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Mart\u00ednez-Mill\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joaqu\u00edn","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00d3scar","family":"Lorenzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas","family":"Egido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"L\u00f3pez-Besc\u00f3s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Tu\u00f1\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,1,19]]},"reference":[{"issue":"1","key":"ref1","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1053\/j.gastro.2009.09.063","article-title":"Famotidine is inferior to pantoprazole in preventing recurrence of aspirin-related peptic ulcers or erosions","volume":"138","author":"F-H Ng","year":"2010","journal-title":"Gastroenterology"},{"issue":"4","key":"ref2","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jcin.2010.12.009","article-title":"Clopidogrel and proton pump inhibitors: influence of pharmacological interactions on clinical outcomes and mechanistic explanations","volume":"4","author":"US Tantry","year":"2011","journal-title":"JACC Cardiovasc Interv"},{"issue":"20","key":"ref3","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1056\/NEJMoa1007964","article-title":"Clopidogrel with or without omeprazole in coronary artery disease","volume":"363","author":"DL Bhatt","year":"2010","journal-title":"N Engl J Med"},{"key":"ref4","unstructured":"Research C for DE and. Postmarket Drug Safety Information for Patients and Providers\u2014FDA Drug Safety Communication: Possible increased risk of fractures of the hip, wrist, and spine with the use of proton pump inhibitors. Center for Drug Evaluation and Research;"},{"issue":"7","key":"ref5","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1001\/jamainternmed.2013.2851","article-title":"Proton pump inhibitors and risk of 1-year mortality and rehospitalization in older patients discharged from acute care hospitals","volume":"173","author":"M Maggio","year":"2013","journal-title":"JAMA Intern Med"},{"issue":"1","key":"ref6","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3949\/ccjm.77a.10087","article-title":"Proton pump inhibitor side effects and drug interactions: much ado about nothing?","volume":"78","author":"RD Madanick","year":"2011","journal-title":"Cleve Clin J Med"},{"issue":"6","key":"ref7","doi-asserted-by":"crossref","first-page":"378","DOI":"10.7326\/0003-4819-153-6-201009210-00005","article-title":"Proton-pump inhibitors are associated with increased cardiovascular risk independent of clopidogrel use: a nationwide cohort study","volume":"153","author":"M Charlot","year":"2010","journal-title":"Ann Intern Med"},{"issue":"6","key":"ref8","doi-asserted-by":"crossref","first-page":"337","DOI":"10.7326\/0003-4819-152-6-201003160-00003","article-title":"Outcomes with concurrent use of clopidogrel and proton-pump inhibitors: a cohort study","volume":"152","author":"WA Ray","year":"2010","journal-title":"Ann Intern Med"},{"issue":"23","key":"ref9","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1161\/CIRCULATIONAHA.109.873497","article-title":"Cardiovascular outcomes and mortality in patients using clopidogrel with proton pump inhibitors after percutaneous coronary intervention or acute coronary syndrome","volume":"120","author":"JA Rassen","year":"2009","journal-title":"Circulation"},{"issue":"3","key":"ref10","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jacc.2007.06.064","article-title":"Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study","volume":"51","author":"M Gilard","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"ref11","unstructured":"Research C for DE and. Drug Safety Information for Heathcare Professionals\u2014Information for Healthcare Professionals: Update to the labeling of Clopidogrel Bisulfate (marketed as Plavix) to alert healthcare professionals about a drug interaction with omeprazole (marketed as P. Center for Drug Evaluation and Research;"},{"issue":"5","key":"ref12","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1046\/j.1365-2036.1997.00216.x","article-title":"Effect of omeprazole on the bioavailability of unmodified and phospholipid-complexed aspirin in rats","volume":"11","author":"MN Giraud","year":"1997","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"ref13","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1161\/CIRCINTERVENTIONS.110.958884","article-title":"Clinical outcomes in patients with the concomitant use of clopidogrel and proton pump inhibitors after percutaneous coronary intervention: an analysis from the Guthrie Health Off-Label Stent (GHOST) investigators","volume":"4","author":"KJ Harjai","year":"2011","journal-title":"Circ Cardiovasc Interv"},{"issue":"9","key":"ref14","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1001\/jama.2009.261","article-title":"Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome","volume":"301","author":"PM Ho","year":"2009","journal-title":"JAMA"},{"issue":"4","key":"ref15","doi-asserted-by":"crossref","first-page":"e95402","DOI":"10.1371\/journal.pone.0095402","article-title":"Coexistence of low vitamin D and high fibroblast growth factor-23 plasma levels predicts an adverse outcome in patients with coronary artery disease","volume":"9","author":"J Tu\u00f1\u00f3n","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"ref16","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.amjcard.2013.10.012","article-title":"Usefulness of a combination of monocyte chemoattractant protein-1, galectin-3, and N-terminal probrain natriuretic peptide to predict cardiovascular events in patients with coronary artery disease","volume":"113","author":"J Tu\u00f1\u00f3n","year":"2014","journal-title":"Am J Cardiol"},{"issue":"5","key":"ref17","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey","volume":"138","author":"R Pisters","year":"2010","journal-title":"Chest"},{"issue":"12","key":"ref18","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1038\/ajg.2010.445","article-title":"ACCF\/ACG\/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF\/ACG\/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID","volume":"105","author":"NS Abraham","year":"2010","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1161\/CIRCULATIONAHA.106.666008","article-title":"Negative inotropy of the gastric proton pump inhibitor pantoprazole in myocardium from humans and rabbits: evaluation of mechanisms","volume":"116","author":"W Schillinger","year":"2007","journal-title":"Circulation"},{"issue":"3","key":"ref20","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1046\/j.0001-6772.2003.01191.x","article-title":"Identification and regulation of the gastric H+\/K+-ATPase in the rat heart","volume":"179","author":"V Beisvag","year":"2003","journal-title":"Acta Physiol Scand"},{"issue":"3","key":"ref21","first-page":"437","article-title":"Effects of different proton pump inhibitors on cardiac contractility in isolated human failing myocardium","volume":"52","author":"S Sossalla","year":"2011","journal-title":"J Cardiovasc Surg (Torino)"},{"issue":"6","key":"ref22","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00392-009-0012-6","article-title":"Recent in vitro findings of negative inotropy of pantoprazole did not translate into clinically relevant effects on left ventricular function in healthy volunteers","volume":"98","author":"W Schillinger","year":"2009","journal-title":"Clin Res Cardiol"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jjcc.2008.05.004","article-title":"Can negative cardiac effect of proton pump inhibitor and high-dose H2-blocker have clinical influence on patients with stable angina?","volume":"52","author":"S Tanaka","year":"2008","journal-title":"J Cardiol"},{"issue":"5","key":"ref24","doi-asserted-by":"crossref","first-page":"488.e9","DOI":"10.1016\/j.jamda.2012.03.003","article-title":"Risk of death associated with use of PPIs in three cohorts of institutionalized older people in Finland","volume":"13","author":"M Teramura-Gr\u00f6nblad","year":"2012","journal-title":"J Am Med Dir Assoc"},{"issue":"17","key":"ref25","first-page":"1604","article-title":"Use of proton pump inhibitors and mortality among institutionalized older people","volume":"170","author":"JS Bell","year":"2010","journal-title":"Arch Intern Med"},{"issue":"2","key":"ref26","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.bpg.2009.11.004","article-title":"Adverse effects of proton pump inhibitors","volume":"24","author":"F Lodato","year":"2010","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"9","key":"ref27","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1001\/archinte.167.9.950","article-title":"Use of proton pump inhibitors and the risk of community-acquired pneumonia: a population-based case-control study","volume":"167","author":"SE Gulmez","year":"2007","journal-title":"Arch Intern Med"},{"issue":"3","key":"ref28","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0195-6701(03)00088-4","article-title":"Proton pump inhibitors as a risk factor for Clostridium difficile diarrhoea","volume":"54","author":"R Cunningham","year":"2003","journal-title":"J Hosp Infect"},{"issue":"3","key":"ref29","doi-asserted-by":"crossref","first-page":"211","DOI":"10.7326\/0003-4819-120-3-199402010-00006","article-title":"Omeprazole therapy causes malabsorption of cyanocobalamin (vitamin B12)","volume":"120","author":"SP Marcuard","year":"1994","journal-title":"Ann Intern Med"},{"issue":"6","key":"ref30","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1097\/MOG.0b013e32833ea9d9","article-title":"Adverse effects of proton pump inhibitor drugs: clues and conclusions","volume":"26","author":"DM McCarthy","year":"2010","journal-title":"Curr Opin Gastroenterol"},{"issue":"5","key":"ref31","first-page":"169","article-title":"Hypomagnesaemia due to use of proton pump inhibitors\u2014a review","volume":"67","author":"MT Kuipers","year":"2009","journal-title":"Neth J Med"},{"issue":"6","key":"ref32","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/qjmed\/hcq021","article-title":"Hypomagnesaemia due to proton-pump inhibitor therapy: A clinical case series","volume":"103","author":"JD Mackay","year":"2010","journal-title":"Qjm"},{"key":"ref33","unstructured":"Blomstr\u00f6m-lundqvist C, Scheinman MM, Aliot EM, Alpert JS, Calkins H, Camm AJ, et al. ACC \/ AHA \/ ESC PRACTICE GUIDELINES\u2014FULL TEXT ACC \/ AHA \/ ESC Guidelines for the Management of Patients With Supraventricular Arrhythmias * and the European Society of Cardiology Committee for Practice Guidelines (Writing. 2003."},{"issue":"9","key":"ref34","first-page":"746","article-title":"2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"8","author":"SG Priori","year":"2015","journal-title":"Eur Heart J"},{"issue":"24","key":"ref35","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1001\/jama.296.24.2947","article-title":"Long-term proton pump inhibitor therapy and risk of hip fracture","volume":"296","author":"Y-X Yang","year":"2006","journal-title":"JAMA"},{"issue":"11","key":"ref36","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1093\/eurjhf\/hfr104","article-title":"Use of oral proton pump inhibitors is not associated with harm in patients with chronic heart failure in an ambulatory setting","volume":"13","author":"GY Oudit","year":"2011","journal-title":"Eur J Heart Fail"},{"issue":"18","key":"ref37","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.3748\/wjg.v18.i18.2161","article-title":"Clopidogrel and proton pump inhibitors\u2014where do we stand in 2012?","volume":"18","author":"MD Drepper","year":"2012","journal-title":"World J Gastroenterol"},{"issue":"Suppl 3","key":"ref38","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1046\/j.1365-2036.1999.00022.x","article-title":"Review article: cytochrome P450 and the metabolism of proton pump inhibitors\u2014emphasis on rabeprazole","volume":"13","author":"T Ishizaki","year":"1999","journal-title":"Aliment Pharmacol Ther"},{"issue":"23","key":"ref39","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1161\/CIRCULATIONAHA.109.873497","article-title":"Cardiovascular outcomes and mortality in patients using clopidogrel with proton pump inhibitors after percutaneous coronary intervention or acute coronary syndrome","volume":"120","author":"JA Rassen","year":"2009","journal-title":"Circulation"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0169826","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T13:55:36Z","timestamp":1589723736000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0169826"}},"subtitle":[],"editor":[{"given":"Raffaele","family":"Bugiardini","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,1,19]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,1,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0169826","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,19]]}}}